OHE
The Office of Health Economics (OHE) is a globally recognised, independent research organisation based in London, UK. OHE has over six decades of experience in conducting rigorous, policy-relevant research in health economics, health technology assessment (HTA), and health policy. Our mission is to inform better decision-making in healthcare through high-quality evidence and analysis. We work with governments, international organisations, academic institutions, and the life sciences industry to address some of the most pressing challenges in healthcare systems—ranging from pricing and reimbursement to innovation adoption and health system sustainability.
OHE’s multidisciplinary team includes economists, statisticians, and policy experts who bring deep expertise in evaluating the value of medical technologies and interventions. Our work supports evidence-based policymaking, improves access to effective treatments, and helps ensure that healthcare resources are used efficiently to maximise patient and societal benefit.
In the TEN4CARE project, OHE leads the economic evaluation and HTA workstream. Our role is to assess the potential clinical and economic impact of the novel tendon repair biomaterials and medical devices being developed. This includes:
- Conducting cost-effectiveness analyses to determine the value of the new technologies compared to current standards of care.
- Estimating broader healthcare system benefits, such as reduced disability, lower relapse rates, and improved patient outcomes.
- Supporting the development of business models and exploitation strategies to facilitate successful market access and adoption.
- Contributing to regulatory and reimbursement planning to ensure alignment with payer and provider expectations.
By embedding health economics into the innovation process, OHE helps ensure that the technologies developed through TEN4CARE are not only scientifically and technically robust but also economically viable and responsive to real-world healthcare needs. Our work supports decision-makers in adopting these advanced treatments, ultimately helping to translate cutting-edge research into tangible improvements in patient care and health system performance.
